三星医疗(601567) - 2017 Q1 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 925,917,712.24, representing a growth of 16.68% year-on-year [6]. - Net profit attributable to shareholders was CNY 87,417,216.97, an increase of 42.05% compared to the same period last year [6]. - Basic earnings per share for the period were CNY 0.07, up 16.67% from CNY 0.06 in the previous year [6]. - The diluted earnings per share were also CNY 0.07, consistent with the basic earnings per share [6]. - Total revenue for Q1 2017 was CNY 925,917,712.24, an increase of 16.67% compared to CNY 793,530,135.26 in the same period last year [25]. - Net profit for Q1 2017 reached CNY 98,990,883.91, an increase of 51.8% compared to CNY 65,228,743.84 in the same period last year [26]. - Operating profit increased to CNY 113,358,297.75, up 71.1% from CNY 66,258,764.15 year-over-year [26]. - The company reported a total comprehensive income of CNY 111,720,124.47 for Q1 2017, compared to CNY 72,789,577.07 in the previous year, marking a growth of 53.4% [27]. - Basic earnings per share for Q1 2017 were CNY 0.07, up from CNY 0.06 in the same quarter last year, reflecting a growth of 16.7% [27]. Cash Flow and Investments - The net cash flow from operating activities was CNY -125,199,072.06, an improvement from CNY -224,523,126.55 in the same period last year [6]. - Cash flow from operating activities increased significantly to CNY 1,220,264,304.54, compared to CNY 884,682,558.53 in the previous year, indicating a growth of 38.0% [32]. - Cash outflow from investing activities amounted to CNY 457,295,958.38, down from CNY 646,659,837.61 in the previous period [33]. - Net cash flow from investing activities was negative at CNY -56,318,299.79, compared to CNY -462,183,248.74 in the previous year [33]. - Cash inflow from financing activities was CNY 277,381,531.99, a decrease from CNY 1,009,505,703.34 year-over-year [34]. - Net cash flow from financing activities was negative at CNY -274,894,976.94, contrasting with a positive CNY 399,948,912.83 in the previous period [34]. - Total cash outflow from operating activities reached CNY 1,499,195,351.93, compared to CNY 1,156,986,674.58 in the previous year [33]. - Cash inflow from sales of goods and services was CNY 354,963,767.46, up from CNY 235,722,224.79 in the previous period [35]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 11,384,573,893.52, a decrease of 2.17% compared to the end of the previous year [6]. - Total assets decreased from CNY 11,636,628,474.95 at the beginning of the year to CNY 11,384,573,893.52 by the end of Q1 2017, a decline of approximately 2.17% [19]. - Total liabilities decreased from CNY 4,712,823,189.98 to CNY 4,359,164,062.81, representing a reduction of about 7.48% [19]. - Current liabilities decreased from CNY 3,606,782,475.01 to CNY 3,257,492,249.85, a decrease of approximately 9.69% [19]. - Non-current liabilities remained relatively stable, with a slight decrease from CNY 1,106,040,714.97 to CNY 1,101,671,812.96 [19]. - Owner's equity increased from CNY 6,923,805,284.97 to CNY 7,025,409,830.71, reflecting a growth of about 1.47% [19]. Shareholder Information - The total number of shareholders at the end of the reporting period was 29,307 [10]. - The largest shareholder, Aux Group Co., Ltd., held 32.26% of the shares [10]. Other Financial Metrics - The weighted average return on equity decreased by 0.88 percentage points to 1.41% [6]. - The company reported non-recurring gains and losses totaling CNY 9,807,682.20 for the period [9]. - The company's prepaid expenses increased by 50.07% to CNY 116,796,210.47 due to a rise in procurement scale and advance payments to suppliers [13]. - Other receivables rose by 68.08% to CNY 144,242,899.98, primarily due to an increase in bid and performance guarantees [13]. - The company's tax payable decreased by 65.76% to CNY 79,600,119.40, mainly due to the payment of taxes at the beginning of the period [13]. - Investment income surged by 2883.77% to CNY 11,313,454.24, attributed to the adjustment of the investment method from cost to equity for a bank investment [13]. - The company reported a significant decrease in tax and additional charges by 62.61% to CNY 1,457,897.03, mainly due to the implementation of the VAT reform policy [13]. - Sales expenses rose to CNY 76,364,482.68, up 27.2% from CNY 60,000,412.41 year-over-year [26]. - The financial expenses showed a significant improvement, with a net income of CNY -3,091,712.61 compared to CNY 21,369,720.64 in the previous year, indicating a reduction in costs [26]. - Other comprehensive income after tax for Q1 2017 was CNY 12,729,240.56, compared to CNY 7,560,833.23 in the previous year, reflecting a growth of 68.0% [27].